Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv

Although currently available model organisms such as Mycobacterium smegmatis and Mycobacterium bovis Bacillus Calmette-Guérin (BCG) have significantly contributed to our understanding of tuberculosis (TB) biology, these models have limitations such as differences in genome size, growth rates and vir...

Full description

Bibliographic Details
Main Authors: Jomien M. Mouton, Tiaan Heunis, Anzaan Dippenaar, James L. Gallant, Léanie Kleynhans, Samantha L. Sampson
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.01922/full
id doaj-57768716271241a6833dcca3dba4ba60
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jomien M. Mouton
Tiaan Heunis
Tiaan Heunis
Anzaan Dippenaar
James L. Gallant
James L. Gallant
Léanie Kleynhans
Samantha L. Sampson
spellingShingle Jomien M. Mouton
Tiaan Heunis
Tiaan Heunis
Anzaan Dippenaar
James L. Gallant
James L. Gallant
Léanie Kleynhans
Samantha L. Sampson
Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv
Frontiers in Microbiology
Mycobacterium tuberculosis
biosafety level 2
attenuated auxotroph
model organism
H37Rv
author_facet Jomien M. Mouton
Tiaan Heunis
Tiaan Heunis
Anzaan Dippenaar
James L. Gallant
James L. Gallant
Léanie Kleynhans
Samantha L. Sampson
author_sort Jomien M. Mouton
title Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv
title_short Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv
title_full Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv
title_fullStr Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv
title_full_unstemmed Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv
title_sort comprehensive characterization of the attenuated double auxotroph mycobacterium tuberculosisδleudδpancd as an alternative to h37rv
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2019-08-01
description Although currently available model organisms such as Mycobacterium smegmatis and Mycobacterium bovis Bacillus Calmette-Guérin (BCG) have significantly contributed to our understanding of tuberculosis (TB) biology, these models have limitations such as differences in genome size, growth rates and virulence. However, attenuated Mycobacterium tuberculosis strains may provide more representative, safer models to study M. tuberculosis biology. For example, the M. tuberculosis ΔleuDΔpanCD double auxotroph, has undergone rigorous in vitro and in vivo safety testing. Like other auxotrophic strains, this has subsequently been approved for use in biosafety level (BSL) 2 facilities. Auxotrophic strains have been assessed as models for drug-resistant M. tuberculosis and for studying latent TB. These offer the potential as safe and useful models, but it is important to understand how well these recapitulate salient features of non-attenuated M. tuberculosis. We therefore performed a comprehensive comparison of M. tuberculosis H37Rv and M. tuberculosisΔleuDΔpanCD. These strains demonstrated similar in vitro and intra-macrophage replication rates, similar responses to anti-TB agents and whole genome sequence conservation. Shotgun proteomics analysis suggested that M. tuberculosisΔleuDΔpanCD has a heightened stress response that leads to reduced bacterial replication during exposure to acid stress, which has been verified using a dual-fluorescent replication reporter assay. Importantly, infection of human peripheral blood mononuclear cells with the 2 strains elicited comparable cytokine production, demonstrating the suitability of M. tuberculosisΔleuDΔpanCD for immunological assays. We provide comprehensive evidence to support the judicious use of M. tuberculosisΔleuDΔpanCD as a safe and suitable model organism for M. tuberculosis research, without the need for a BSL3 facility.
topic Mycobacterium tuberculosis
biosafety level 2
attenuated auxotroph
model organism
H37Rv
url https://www.frontiersin.org/article/10.3389/fmicb.2019.01922/full
work_keys_str_mv AT jomienmmouton comprehensivecharacterizationoftheattenuateddoubleauxotrophmycobacteriumtuberculosisdleuddpancdasanalternativetoh37rv
AT tiaanheunis comprehensivecharacterizationoftheattenuateddoubleauxotrophmycobacteriumtuberculosisdleuddpancdasanalternativetoh37rv
AT tiaanheunis comprehensivecharacterizationoftheattenuateddoubleauxotrophmycobacteriumtuberculosisdleuddpancdasanalternativetoh37rv
AT anzaandippenaar comprehensivecharacterizationoftheattenuateddoubleauxotrophmycobacteriumtuberculosisdleuddpancdasanalternativetoh37rv
AT jameslgallant comprehensivecharacterizationoftheattenuateddoubleauxotrophmycobacteriumtuberculosisdleuddpancdasanalternativetoh37rv
AT jameslgallant comprehensivecharacterizationoftheattenuateddoubleauxotrophmycobacteriumtuberculosisdleuddpancdasanalternativetoh37rv
AT leaniekleynhans comprehensivecharacterizationoftheattenuateddoubleauxotrophmycobacteriumtuberculosisdleuddpancdasanalternativetoh37rv
AT samanthalsampson comprehensivecharacterizationoftheattenuateddoubleauxotrophmycobacteriumtuberculosisdleuddpancdasanalternativetoh37rv
_version_ 1724971980794363904
spelling doaj-57768716271241a6833dcca3dba4ba602020-11-25T01:57:51ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-08-011010.3389/fmicb.2019.01922472559Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37RvJomien M. Mouton0Tiaan Heunis1Tiaan Heunis2Anzaan Dippenaar3James L. Gallant4James L. Gallant5Léanie Kleynhans6Samantha L. Sampson7Department of Science and Technology/National Research Foundation (DST/NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaDepartment of Science and Technology/National Research Foundation (DST/NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, United KingdomDepartment of Science and Technology/National Research Foundation (DST/NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaDepartment of Science and Technology/National Research Foundation (DST/NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaSection of Molecular Microbiology, Amsterdam Institute of Molecules, Medicines, and Systems, Vrije Universiteit Amsterdam, Amsterdam, NetherlandsDepartment of Science and Technology/National Research Foundation (DST/NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaDepartment of Science and Technology/National Research Foundation (DST/NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaAlthough currently available model organisms such as Mycobacterium smegmatis and Mycobacterium bovis Bacillus Calmette-Guérin (BCG) have significantly contributed to our understanding of tuberculosis (TB) biology, these models have limitations such as differences in genome size, growth rates and virulence. However, attenuated Mycobacterium tuberculosis strains may provide more representative, safer models to study M. tuberculosis biology. For example, the M. tuberculosis ΔleuDΔpanCD double auxotroph, has undergone rigorous in vitro and in vivo safety testing. Like other auxotrophic strains, this has subsequently been approved for use in biosafety level (BSL) 2 facilities. Auxotrophic strains have been assessed as models for drug-resistant M. tuberculosis and for studying latent TB. These offer the potential as safe and useful models, but it is important to understand how well these recapitulate salient features of non-attenuated M. tuberculosis. We therefore performed a comprehensive comparison of M. tuberculosis H37Rv and M. tuberculosisΔleuDΔpanCD. These strains demonstrated similar in vitro and intra-macrophage replication rates, similar responses to anti-TB agents and whole genome sequence conservation. Shotgun proteomics analysis suggested that M. tuberculosisΔleuDΔpanCD has a heightened stress response that leads to reduced bacterial replication during exposure to acid stress, which has been verified using a dual-fluorescent replication reporter assay. Importantly, infection of human peripheral blood mononuclear cells with the 2 strains elicited comparable cytokine production, demonstrating the suitability of M. tuberculosisΔleuDΔpanCD for immunological assays. We provide comprehensive evidence to support the judicious use of M. tuberculosisΔleuDΔpanCD as a safe and suitable model organism for M. tuberculosis research, without the need for a BSL3 facility.https://www.frontiersin.org/article/10.3389/fmicb.2019.01922/fullMycobacterium tuberculosisbiosafety level 2attenuated auxotrophmodel organismH37Rv